WSU-DLCL-2
文献支持

WSU-DLCL-2

收藏
  • ¥2480
  • EK-Bioscience已认证
  • CA-Y1780
  • 2025年07月11日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    WSU-DLCL-2细胞WSU-DLCL-2细胞WSU-DLCL-2;人弥漫大B淋巴瘤细胞

    Cell line name WSU-DLCL2

    Synonyms WSU-DLCL-2; WSU-DLCL(2); WSUDLCL2

    Accession CVCL_1902

    Resource Identification Initiative To cite this cell line use: WSU-DLCL2 (RRID:CVCL_1902)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: LL-100 blood cancer cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Part of: TCGA-110-CL cell line panel.

    Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11585.

    Population: Caucasian.

    Doubling time: 18 hours (PubMed=9607591); ~50-70 hours (DSMZ=ACC-575).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Genome sequenced.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Omics: Virome analysis using RNAseq.

    Misspelling: WSU-DCL2; GEO=GSM1374991.

    Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175

    PubMed=19358282; DOI=10.1002/ijc.24351

    Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M., Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.

    Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

    Int. J. Cancer 125:212-221(2009)

     

    PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

    Nature 483:603-607(2012)

     

    PubMed=23699601; DOI=10.1182/blood-2013-02-483727; PMCID=PMC3744992

    Morin R.D., Mungall K., Pleasance E.D., Mungall A.J., Goya R., Huff R.D., Scott D.W., Ding J.-R., Roth A., Chiu R., Corbett R.D., Chan F.C., Mendez-Lago M., Trinh D.L., Bolger-Munro M., Taylor G., Hadj Khodabakhshi A., Ben-Neriah S., Pon J., Meissner B., Woolcock B.W., Farnoud N., Rogic S., Lim E.L., Johnson N.A., Shah S.P., Jones S.J.M., Steidl C., Holt R.A., Birol I., Moore R., Connors J.M., Gascoyne R.D., Marra M.A.

    Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

    Blood 122:1256-1265(2013)

     

    PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981

    Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

    A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

    OncoImmunology 3:e954893.1-e954893.12(2014)

     

    PubMed=25355872; DOI=10.1128/JVI.02570-14; PMCID=PMC4301145

    Cao S.-B., Strong M.J., Wang X., Moss W.N., Concha M., Lin Z., O'Grady T., Baddoo M., Fewell C., Renne R., Flemington E.K.

    High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

    J. Virol. 89:713-729(2015)

     

    PubMed=25485619; DOI=10.1038/nbt.3080

    Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.

    A comprehensive transcriptional portrait of human cancer cell lines.

    Nat. Biotechnol. 33:306-312(2015)

     

    PubMed=25877200; DOI=10.1038/nature14397

    Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.

    A resource for cell line authentication, annotation and quality control.

    Nature 520:307-311(2015)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2450
    博辉生物科技(广州)有限公司
    2025年12月05日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月12日询价
    询价
    上海晶风生物科技有限公司
    2025年07月06日询价
    ¥2480
    上海酶研生物科技有限公司
    2025年07月13日询价
    询价
    上海彩佑实业有限公司
    2025年06月29日询价
    文献支持
    WSU-DLCL-2
    ¥2480